HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-12Clinical Trial Update: HIV Testing in Non-traditional Settings Study
The HIV testing in non-traditional settings study has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya [NA]
This clinical trial evaluated integrating HIV care and treatment into antenatal care in Migori District, Kenya; the study status is Complete…
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease [Phase 2]
A Phase 2 pilot, randomized, placebo-controlled study evaluated Lovaza in cardiovascular disease; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected Adults [Phase 2]
Phase 2 trial evaluating the safety and efficacy of salsalate for endothelial dysfunction in HIV-infected adults. Results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study. [Phase 1]
This Phase 1 study assessed possible drug interactions between methadone and dolutegravir (GSK1349572) in individuals with HIV infection and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-04-06FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
The FDA approved a supplemental application for VIRACEPT (nelfinavir mesylate) from Agouron.
-
FDA approval · 2012-04-06FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for Viracept (nelfinavir mesylate) submitted by Agouron Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients [Phase 2]
Phase 2 trial update on the pharmacokinetics of double-boosted protease inhibitors in antiretroviral-naive HIV-1 infected patients.
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r
A completed clinical trial evaluated genetic polymorphisms in Thai patients with HIV-1 infection who were treated with saquinavir/ritonavir …
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Housing and Health Study [NA]
The Housing and Health Study sponsored by the Centers for Disease Control and Prevention has completed, examining housing-related health out…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Pharmacokinetics of Low Dose Ritonavir [Phase 1, Phase 2]
A Phase 1/2 pharmacokinetics study of low-dose ritonavir in HIV infection has been completed.
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: ADAPT-POL: Planned Parenthood Center of El Paso Adopting and Demonstrating the Adaptation of Prevention Techniques [NA]
The ADAPT-POL trial at the Planned Parenthood Center of El Paso, sponsored by the CDC, has completed evaluation of prevention techniques for…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Influenza Vaccine in HIV Infected Children [Phase 4]
A Phase 4 clinical trial update on an influenza vaccine in HIV-infected children, with the study status showing completion.
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal. [Phase 1]
Phase 1 study in healthy volunteers to assess the oral bioavailability of cabotegravir (GSK1265744) under fasted and fed conditions.
-
CLINICAL_TRIALS trial_result · 2012-04-02Clinical Trial Update: Botswana Pediatric Respiratory Disease and Bloodstream Infection Study
A Botswana pediatric clinical trial evaluating respiratory disease and bloodstream infection, sponsored by Harvard School of Public Health, …
-
CLINICAL_TRIALS trial_result · 2012-03-29Clinical Trial Update: Impact of Peer Health Workers and Mobile Phones on HIV Care [NA]
Clinical trial from Johns Hopkins assessed the impact of peer health workers and mobile phone interventions on HIV care outcomes; the study …
-
CLINICAL_TRIALS withdrawal · 2012-03-29Clinical Trial Update: Pharmacokinetics of Raltegravir During Third Trimester Pregnancy and Post-Partum
A clinical trial evaluating the pharmacokinetics of raltegravir during the third trimester of pregnancy and postpartum has been withdrawn.
-
FDA approval · 2012-03-28FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for ISENTRESS (raltegravir) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS withdrawal · 2012-03-28Clinical Trial Update: Pharmacotherapy for HIV Infected Patients With Alcohol Problems [Phase 4]
Phase 4 clinical trial update on pharmacotherapy for HIV-infected patients with alcohol problems; the study status has been withdrawn.
-
FDA approval · 2012-03-26FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
The FDA approved a supplemental application for etravirine submitted by Patriot Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults [Phase 3]
A Phase 3 trial update reports results for treatment-naive HIV-1 adults treated with regimens containing Nevirapine or Atazanavir/Ritonavir …
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: Artery Elasticity After Switch From Epzicom to Truvada [Phase 4]
Phase 4 trial evaluating arterial elasticity after switching from Epzicom to Truvada in HIV infection; the study was terminated and results …
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the Cervix [NA]
A completed clinical trial sponsored by the University of Toronto evaluating whether herpes simplex virus type 2 therapy can reduce HIV targ…
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Atazanavir/Ritonavir and Zinc Pharmacokinetic Study [Phase 4]
Phase 4 pharmacokinetic study evaluating potential pharmacokinetic interaction between Atazanavir/Ritonavir and zinc in HIV-infected individ…
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients [NA]
This update reports on the medical and economic implications of using Interferon-Gamma Release Assays (IGRAs) to diagnose latent tuberculosi…